Skip to content
Recall Observatory FDA recall evidence

Drug product

Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017, NDC 0069-0106-01

D-0005-2019

September 19, 2018

Class II

Product summary

Firm
Pfizer Inc.
Event
Event 81050
Status
Terminated
Classification
Class II
Quantity
12,416 vials
Official record key
drug-enforcement:D-0005-2019

Official wording

Reason: Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.

Code information: Lot S91616

Distribution pattern: U.S.A. nationwide. The following countries received product from Lot S91616: Albania, South Africa, Israel, Afghanistan, Rwanda, Botswana, Zimbabwe and Iraq as part of the Compassionate Use Program.

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of assurance of sterility